NRx agrees to relinquish rights to experimental Covid-19 therapy in settlement with Relief Therapeutics


Radnor-based NRx Pharmaceuticals is transferring to Relief Therapeutics all the assets it previously used in the development of Zyesami.

Previous New affiliate network brings two of region's largest nonprofits together
Next High Vibe, Mane is a Memphis shop/brand in the 'anything is possible' business